Researchers discuss common therapies that may cause health problems in seniors

Share this article:
Two therapies commonly prescribed to seniors carry some significant risks, according to reports presented in Chicago during this week's Digestive Disease Week.

Complex antithrombic therapy, which is typically prescribed to patients with a history of stroke, heart attack or peripheral vascular disease, has been found to be associated with heightened risk of bleeding or perforation of the upper gastrointestinal tract, according to researchers. Common treatments include anticoagulant-antiplatelet (ACAP) therapy, aspirin-antiplatelet (ASAP) therapy, aspirin-anticoagulant (ASAC) therapy or TRIP (aspirin-anticoagulant-antiplatelet) therapy. The safest therapy was ACAP, according to researchers from the University of North Carolina School of Medicine, who presented their findings May 31. Those receiving the other types of therapy had a heightened risk of an upper gastrointestinal event.

Meanwhile, proton pump inhibitors and histamine-2 receptor antagonists are used to reduce stomach acid production. But according to new research, the therapies also contribute to a dramatic increase in the risk of hip or femur fracture. The average dose of PPIs or H2RAs is on pill per day, researchers told the conference Monday, and those receiving that dosage are 30% more likely to suffer a fractured hip or femur. Those receiving a higher dose had a 41% risk increase. This year's Digestive Disease Week is being held at McCormack Place, Chicago, between May 30 and June 4. More than 5,000 studies relating to gastrointestinal health will be on offer.
Share this article:

More in News

Large hepatitis outbreak reaches 47 cases, podiatry company denies ManorCare's charges

The number of people infected in an infamous North Dakota Hepatitis C outbreak has risen, state health officials say.

National Quality Forum supports quality measures in bill to standardize post-acute assessments

National Quality Forum supports quality measures in bill ...

The National Quality Forum has come out in strong support of a proposed standardized quality measures, such as skin integrity, across different types of post-acute care settings. Uniform assessments are ...

CMS changes mind on hospice drugs

The Centers for Medicaid & Medicare Services has revised guidance on authorization of hospice drugs for those under Medicare Advantage and Part D plans, according to a new memo.